Connection

RAJYALAKSHMI LUTHRA to Safety

This is a "connection" page, showing publications RAJYALAKSHMI LUTHRA has written about Safety.
Connection Strength

0.035
  1. A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis. Blood. 2018 10 18; 132(16):1664-1674.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.